开云app官网登录入口网页版-官方正版

#EMT#

32篇内容 | 1811人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2177102, encodeId=be3d21e7102b5, content=<a href='/topic/show?id=08f236865a8' target=_blank style='color:#2F92EE;'>#卵巢癌#</a> <a href='/topic/show?id=053d2148601' target=_blank style='color:#2F92EE;'>#中医药#</a> <a href='/topic/show?id=684f16e52c8' target=_blank style='color:#2F92EE;'>#STAT3#</a> <a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a> <a href='/topic/show?id=446d10451504' target=_blank style='color:#2F92EE;'>#桂枝茯苓丸#</a> <a href='/topic/show?id=ed6b109140eb' target=_blank style='color:#2F92EE;'>#缺氧应激#</a>, objectTitle=Biomed Pharmacother：转录组学和蛋白质组学分析显示桂枝茯苓丸抑制STAT3-EMT在卵巢癌进展中的作用, objectType=article, longId=806881, objectId=400f8068810e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20231225/1703485681197_5610093.jpg, objectUrl=/article/show_article.do?id=400f8068810e, replyNumber=0, likeNumber=101, createdTime=2023-12-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=400f8068810e, moduleTitle=Biomed Pharmacother：转录组学和蛋白质组学分析显示桂枝茯苓丸抑制STAT3-EMT在卵巢癌进展中的作用, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=400f8068810e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1462143, encodeId=aa001462143d1, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=Trastuzumab Deruxtecan治疗HER2阳性乳腺癌效果优于trastuzumab emtansine, objectType=article, longId=725405, objectId=f586e25405ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f586e25405ed, replyNumber=0, likeNumber=79, createdTime=2022-04-27, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f586e25405ed, moduleTitle=Trastuzumab Deruxtecan治疗HER2阳性乳腺癌效果优于trastuzumab emtansine, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f586e25405ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462142, encodeId=7274146214277, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=NEJM：Trastuzumab deruxtecan vs Trastuzumab emtansine治疗HER2阳性转移性乳腺癌, objectType=article, longId=301648, objectId=93a0301648a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93a0301648a6, replyNumber=0, likeNumber=0, createdTime=2022-03-27, rootId=0, userName=lfcmxl, userId=1f216475172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93a0301648a6, moduleTitle=NEJM：Trastuzumab deruxtecan vs Trastuzumab emtansine治疗HER2阳性转移性乳腺癌, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=93a0301648a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462141, encodeId=cd491462141f4, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=European Radiology：如何应用CT预测胃癌的EMT分子亚型？, objectType=article, longId=295738, objectId=61cc295e3827, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61cc295e3827, replyNumber=0, likeNumber=75, createdTime=2022-02-17, rootId=0, userName=lfcmxl, userId=1f216475172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61cc295e3827, moduleTitle=European Radiology：如何应用CT预测胃癌的EMT分子亚型？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=61cc295e3827)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462140, encodeId=d0131462140b0, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=Journal of Tissue Viability：微电流疗法（EMT）能够有效促进伤口愈合, objectType=article, longId=292086, objectId=a03b2920860f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a03b2920860f, replyNumber=0, likeNumber=90, createdTime=2021-12-18, rootId=0, userName=lfcmxl, userId=1f216475172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a03b2920860f, moduleTitle=Journal of Tissue Viability：微电流疗法（EMT）能够有效促进伤口愈合, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=a03b2920860f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462139, encodeId=452b1462139fa, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=JCO：Gemtuzumab Ozogamicin可改善KMT2A重排型AML患儿预后、减少复发！, objectType=article, longId=212166, objectId=c8ad21216642, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8ad21216642, replyNumber=0, likeNumber=77, createdTime=2021-06-03, rootId=0, userName=lfcmxl, userId=1f216475172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8ad21216642, moduleTitle=JCO：Gemtuzumab Ozogamicin可改善KMT2A重排型AML患儿预后、减少复发！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c8ad21216642)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462138, encodeId=7a3c1462138ff, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=Br J Cancer：miR-199b-5p-DDR1-ERK信号通路介导EMT进程抑制前列腺癌的转移, objectType=article, longId=204410, objectId=a0772044103d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0772044103d, replyNumber=0, likeNumber=81, createdTime=2020-12-13, rootId=0, userName=lfcmxl, userId=1f216475172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0772044103d, moduleTitle=Br J Cancer：miR-199b-5p-DDR1-ERK信号通路介导EMT进程抑制前列腺癌的转移, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=a0772044103d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462137, encodeId=33dc146213e9e, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=赛诺菲的四价流感疫苗Supemtek在欧盟获批，用于预防流感, objectType=article, longId=203566, objectId=23fe20356626, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23fe20356626, replyNumber=0, likeNumber=104, createdTime=2020-11-21, rootId=0, userName=lfcmxl, userId=1f216475172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23fe20356626, moduleTitle=赛诺菲的四价流感疫苗Supemtek在欧盟获批，用于预防流感, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=23fe20356626)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462136, encodeId=5c391462136ba, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=Dev Cell ：利用谱系示踪技术无缝隙捕捉体内肿瘤转移中的EMT过程, objectType=article, longId=198351, objectId=5df0198351c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5df0198351c5, replyNumber=0, likeNumber=78, createdTime=2020-07-31, rootId=0, userName=lfcmxl, userId=1f216475172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5df0198351c5, moduleTitle=Dev Cell ：利用谱系示踪技术无缝隙捕捉体内肿瘤转移中的EMT过程, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=5df0198351c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462135, encodeId=535614621353c, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=Blood：EMT调控因子SNAI1通过与LSD1相互作用促进AML进展, objectType=article, longId=194257, objectId=cebe19425e1c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cebe19425e1c, replyNumber=0, likeNumber=73, createdTime=2020-05-18, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cebe19425e1c, moduleTitle=Blood：EMT调控因子SNAI1通过与LSD1相互作用促进AML进展, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=cebe19425e1c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462134, encodeId=9a191462134f3, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=Cell Death Dis：CD73通过调节RICS/RhoA信号及EMT进程促进胃癌转移, objectType=article, longId=191300, objectId=beca19130098, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=beca19130098, replyNumber=0, likeNumber=69, createdTime=2020-04-04, rootId=0, userName=lfcmxl, userId=1f216475172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=beca19130098, moduleTitle=Cell Death Dis：CD73通过调节RICS/RhoA信号及EMT进程促进胃癌转移, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=beca19130098)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462133, encodeId=e9d7146213374, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=Cytokinetics的快速骨骼肌肌钙蛋白激活剂Reldesemtiv获得欧洲孤儿药称号，用于治疗肌萎缩性侧索硬化症, objectType=article, longId=189514, objectId=6bd71895142a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bd71895142a, replyNumber=0, likeNumber=89, createdTime=2020-03-08, rootId=0, userName=lfcmxl, userId=1f216475172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bd71895142a, moduleTitle=Cytokinetics的快速骨骼肌肌钙蛋白激活剂Reldesemtiv获得欧洲孤儿药称号，用于治疗肌萎缩性侧索硬化症, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=6bd71895142a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462132, encodeId=4aa51462132ef, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=Sci Rep：非小细胞肺癌中IL-1β诱导的慢性炎症通过表观遗传修饰调节EMT记忆表型, objectType=article, longId=186368, objectId=b9b618636880, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9b618636880, replyNumber=0, likeNumber=70, createdTime=2020-01-18, rootId=0, userName=lfcmxl, userId=1f216475172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9b618636880, moduleTitle=Sci Rep：非小细胞肺癌中IL-1β诱导的慢性炎症通过表观遗传修饰调节EMT记忆表型, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=b9b618636880)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462131, encodeId=0c57146213199, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=Cell Death Dis：miR-137通过靶向DUSP4抑制EMT减弱乳腺癌对阿霉素的耐药性, objectType=article, longId=185079, objectId=f7b41850e9d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7b41850e9d6, replyNumber=0, likeNumber=70, createdTime=2019-12-24, rootId=0, userName=lfcmxl, userId=1f216475172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7b41850e9d6, moduleTitle=Cell Death Dis：miR-137通过靶向DUSP4抑制EMT减弱乳腺癌对阿霉素的耐药性, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f7b41850e9d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462130, encodeId=3f7a146213096, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=由于毒副作用，欧洲药品管理局建议限制Lemtrada在多发性硬化症中的使用, objectType=article, longId=164344, objectId=ad231643441f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad231643441f, replyNumber=0, likeNumber=66, createdTime=2019-04-17, rootId=0, userName=lfcmxl, userId=1f216475172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad231643441f, moduleTitle=由于毒副作用，欧洲药品管理局建议限制Lemtrada在多发性硬化症中的使用, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=ad231643441f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462129, encodeId=101d14621299d, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=NEJM：Trastuzumab emtansine治疗残留浸润型乳腺癌效果显著, objectType=article, longId=160000, objectId=09b4160000c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09b4160000c1, replyNumber=0, likeNumber=78, createdTime=2019-02-16, rootId=0, userName=lfcmxl, userId=1f216475172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09b4160000c1, moduleTitle=NEJM：Trastuzumab emtansine治疗残留浸润型乳腺癌效果显著, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=09b4160000c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462128, encodeId=d48c1462128cd, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=Nature：肿瘤有7种EMT状态，从而找出肿瘤转移的罪魁祸首！, objectType=article, longId=136046, objectId=698113604632, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=698113604632, replyNumber=0, likeNumber=94, createdTime=2018-04-22, rootId=0, userName=lfcmxl, userId=1f216475172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=698113604632, moduleTitle=Nature：肿瘤有7种EMT状态，从而找出肿瘤转移的罪魁祸首！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=698113604632)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462127, encodeId=8884146212e7c, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=Sci Rep：EMT和MET miRNA调控在乳腺癌中的网络分析, objectType=article, longId=118909, objectId=fe891189090e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe891189090e, replyNumber=0, likeNumber=62, createdTime=2017-11-07, rootId=0, userName=lfcmxl, userId=1f216475172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe891189090e, moduleTitle=Sci Rep：EMT和MET miRNA调控在乳腺癌中的网络分析, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=fe891189090e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462126, encodeId=509d146212614, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=Lancet Oncol：trastuzumab emtansine对晚期乳腺癌患者临床研究最终结果分析, objectType=article, longId=98927, objectId=a46a9892e56, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a46a9892e56, replyNumber=0, likeNumber=58, createdTime=2017-05-19, rootId=0, userName=lfcmxl, userId=1f216475172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a46a9892e56, moduleTitle=Lancet Oncol：trastuzumab emtansine对晚期乳腺癌患者临床研究最终结果分析, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=a46a9892e56)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1462125, encodeId=199e1462125e9, content=<a href='/topic/show?id=c6436e385a' target=_blank style='color:#2F92EE;'>#EMT#</a>, objectTitle=Lancet Oncol：trastuzumab emtansine III期试验最终数据分析, objectType=article, longId=98926, objectId=79479892694, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79479892694, replyNumber=0, likeNumber=70, createdTime=2017-05-19, rootId=0, userName=lfcmxl, userId=1f216475172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79479892694, moduleTitle=Lancet Oncol：trastuzumab emtansine III期试验最终数据分析, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=79479892694)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

EMT

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#卵巢癌# #中医药# #STAT3# #EMT# #桂枝茯苓丸# #缺氧应激#

Biomed Pharmacother：转录组学和蛋白质组学分析显示桂枝茯苓丸抑制STAT3-EMT在卵巢癌进展中的作用

2023-12-25发表于上海

zhouqu_8 (审核中...)

前往app查看评论内容

#EMT#

Trastuzumab Deruxtecan治疗HER2阳性乳腺癌效果优于trastuzumab emtansine

2022-04-27

lfcmxl (审核中...)

前往app查看评论内容

#EMT#

NEJM：Trastuzumab deruxtecan vs Trastuzumab emtansine治疗HER2阳性转移性乳腺癌

2022-03-27

lfcmxl (审核中...)

前往app查看评论内容

#EMT#

European Radiology：如何应用CT预测胃癌的EMT分子亚型？

2022-02-17

lfcmxl (审核中...)

前往app查看评论内容

#EMT#

Journal of Tissue Viability：微电流疗法（EMT）能够有效促进伤口愈合

2021-12-18

lfcmxl (审核中...)

前往app查看评论内容

#EMT#

JCO：Gemtuzumab Ozogamicin可改善KMT2A重排型AML患儿预后、减少复发！

2021-06-03

lfcmxl (审核中...)

前往app查看评论内容

#EMT#

Br J Cancer：miR-199b-5p-DDR1-ERK信号通路介导EMT进程抑制前列腺癌的转移

2020-12-13

lfcmxl (审核中...)

前往app查看评论内容

#EMT#

赛诺菲的四价流感疫苗Supemtek在欧盟获批，用于预防流感

2020-11-21

lfcmxl (审核中...)

前往app查看评论内容

#EMT#

Dev Cell ：利用谱系示踪技术无缝隙捕捉体内肿瘤转移中的EMT过程

2020-07-31

zhaojie88 (审核中...)

前往app查看评论内容

#EMT#

Blood：EMT调控因子SNAI1通过与LSD1相互作用促进AML进展

2020-05-18

lfcmxl (审核中...)

前往app查看评论内容

#EMT#

Cell Death Dis：CD73通过调节RICS/RhoA信号及EMT进程促进胃癌转移

2020-04-04

lfcmxl (审核中...)

前往app查看评论内容

#EMT#

Cytokinetics的快速骨骼肌肌钙蛋白激活剂Reldesemtiv获得欧洲孤儿药称号，用于治疗肌萎缩性侧索硬化症

2020-03-08

lfcmxl (审核中...)

前往app查看评论内容

#EMT#

Sci Rep：非小细胞肺癌中IL-1β诱导的慢性炎症通过表观遗传修饰调节EMT记忆表型

2020-01-18

lfcmxl (审核中...)

前往app查看评论内容

#EMT#

Cell Death Dis：miR-137通过靶向DUSP4抑制EMT减弱乳腺癌对阿霉素的耐药性

2019-12-24

lfcmxl (审核中...)

前往app查看评论内容

#EMT#

由于毒副作用，欧洲药品管理局建议限制Lemtrada在多发性硬化症中的使用

2019-04-17

lfcmxl (审核中...)

前往app查看评论内容

#EMT#

NEJM：Trastuzumab emtansine治疗残留浸润型乳腺癌效果显著

2019-02-16

lfcmxl (审核中...)

前往app查看评论内容

#EMT#

Nature：肿瘤有7种EMT状态，从而找出肿瘤转移的罪魁祸首！

2018-04-22

lfcmxl (审核中...)

前往app查看评论内容

#EMT#

Sci Rep：EMT和MET miRNA调控在乳腺癌中的网络分析

2017-11-07

lfcmxl (审核中...)

前往app查看评论内容

#EMT#

Lancet Oncol：trastuzumab emtansine对晚期乳腺癌患者临床研究最终结果分析

2017-05-19

lfcmxl (审核中...)

前往app查看评论内容

#EMT#

Lancet Oncol：trastuzumab emtansine III期试验最终数据分析

2017-05-19

科室
- - 订阅+
  - 更多科室
工具
服务